Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksMEDANTA
resources
MEDANTA

Global Health Ltd.

NSE: MEDANTA
BSE: 543654
Sector: Healthcare
Industry Group: Healthcare Services
Industry: Hospital
1,280.00-0.2 (-0.02%)
14 Oct, 12:00 AM

Annual Reports and Financial Documents

Global Health Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Global Health Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please find attached herewith the Certificates issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 by RTA for the Quarter ended September 30, 2026.
  2. General5 Oct 2026
    Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 - ESG Rating Assigned By Crisil ESG Ratings & Analytics Limited.
    Intimation Under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 - ESG Rating assigned by Crisil ESG Ratings & Analytics Limited.
  3. Press Release / Media Release29 Sept 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Medanta to expand Healthcare Footprint in Uttar Pradesh with the Acquisition of 10,560 Sq. Meter Land Parcel in Ghaziabad.
  4. General28 Sept 2026
    Intimation Under Regulation 30 Of The Listing Regulations.
    Intimation Under Regulation 30 of Listing Regulations.
  5. Closure of Trading Window24 Sept 2026
    Closure of Trading Window
    Intimation regarding closure of Trading Window for the Second Quarter ended on September 30, 2026.
  6. Analyst / Investor Meet22 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  7. Allotment of ESOP / ESPS22 Sept 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Intimation under Regulation 30 of Listing Regulations regarding allotment of shares.
  8. Analyst / Investor Meet17 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  9. AGM16 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Enclosed Scrutinizer Report and Voting Results of 22nd Annual General Meeting of the Company.
  10. AGM16 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceeding of 22nd Annual General Meeting of the Company held on September 16, 2026, at 12:00 Noon.
  11. Analyst / Investor Meet11 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  12. Analyst / Investor Meet11 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  13. Analyst / Investor Meet10 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  14. Analyst / Investor Meet9 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  15. Analyst / Investor Meet3 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  16. Analyst / Investor Meet3 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  17. Analyst / Investor Meet31 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  18. Analyst / Investor Meet31 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  19. Analyst / Investor Meet25 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
  20. Analyst / Investor Meet22 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

Frequently Asked Questions

Where can I download the annual report of Global Health Ltd.?
Annual reports of Global Health Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Global Health Ltd.?
Quarterly earnings results and presentations of Global Health Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Global Health Ltd. publish earnings call transcripts?
Earnings call transcripts of Global Health Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Global Health Ltd.?
Investor presentations and annual day presentations of Global Health Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Global Health Ltd.?
Corporate announcements and regulatory filings of Global Health Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Global Health Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Global Health Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Global Health Ltd.?
The ISIN (International Securities Identification Number) of Global Health Ltd. is INE474Q01031. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Global Health Ltd. listed?
Global Health Ltd. is listed on NSE and BSE. The NSE symbol is MEDANTA and the BSE code is -.
Where can I find the shareholding pattern of Global Health Ltd.?
The quarterly shareholding pattern of Global Health Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Global Health Ltd. on Sharpely?
Share price data for Global Health Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.